Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/10/1991 | US5071657 Device for transdermal administration of active medicinal agents |
12/10/1991 | US5071656 Nitroglycerin delivery to skin or mucosa |
12/10/1991 | US5071646 Pharmaceutical ion exchange resin composition |
12/10/1991 | US5071645 Process of producing an active agent delivery device |
12/10/1991 | US5071644 Using aqueous gel |
12/10/1991 | US5071643 Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
12/10/1991 | US5071642 Nifedipine, nimodipine, nicardipine, nitrendipine, nisoldipine or felodipine drugs for treatment of circulatory disorders and high blood pressure |
12/10/1991 | US5070889 Containing iodine and chlohexidine in polyester foam |
12/10/1991 | CA1292946C Method for inhibiting post-surgical adhesion formation by the topical administration of non- steroidal anti-inflammatory drug |
12/10/1991 | CA1292944C Preparation process for an aqueous pharmaceutical solution of an active principle constituted by an organic acid |
12/10/1991 | CA1292913C Sustained release pharmaceutical preparation comprising multilayer granules |
12/09/1991 | WO1991018669A1 Process for preparing microemulsion |
12/09/1991 | CA2083711A1 Process for preparing microemulsion |
12/05/1991 | WO1991018927A1 Method for preparing interferon alpha-2 crystals |
12/05/1991 | CA2084406A1 Method for preparing interferon alpha-2 crystals |
12/04/1991 | EP0459856A1 Cosmetic or pharmaceutical composition for hair and scalp treatment |
12/04/1991 | EP0459818A1 Peel-openable container for suppository |
12/04/1991 | EP0459795A1 Oral dosage form of biologically active proteins |
12/04/1991 | EP0459733A2 Alginate gels |
12/04/1991 | EP0459695A1 Taste masking and sustained release coatings for pharmaceuticals |
12/04/1991 | EP0459516A1 Oral dosage form of biologically active proteins |
12/04/1991 | EP0459462A1 Xylobiose containing composition |
12/04/1991 | EP0459378A1 Gels in the form of highly hydrated self-supporting film, the process for their preparation, and their use in the therapy of cutaneous lesions and/or pathologies |
12/04/1991 | EP0459377A2 Use of E1 prostaglandin to cure male erectile inpotence |
12/04/1991 | EP0459281A2 Method for making a microencapsulated liquid crystal |
12/04/1991 | EP0459148A2 Dry eye treatment composition |
12/04/1991 | EP0459059A2 Tearable, continuous film medical PSA tape |
12/04/1991 | EP0458924A1 Pharmaceutical preparations |
12/04/1991 | EP0458887A1 Dispensing device |
12/04/1991 | EP0458835A1 Dispensing device |
12/04/1991 | CN1056634A Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
12/03/1991 | US5070107 Aliphatic straight-chain alcohols having 27 to 32 carbons in t he chain |
12/03/1991 | US5070104 Methods of chelating metal and novel compositions therefor |
12/03/1991 | US5070081 Agitation in presence of small amount of water |
12/03/1991 | US5069936 Manufacturing protein microspheres |
12/03/1991 | US5069911 Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions |
12/03/1991 | US5069910 Dispersible cimetidine tablets |
12/03/1991 | US5069909 Transdermal administration of buprenorphine |
12/03/1991 | US5069908 Transdermal drug delivery, aluminum acetate |
12/03/1991 | US5069906 Intra-vaginal device and method |
12/03/1991 | US5069904 Alzheimer's disease |
12/03/1991 | CA1292701C Curable compositions for dental drugs having sustained release property |
12/03/1991 | CA1292697C Transdermal administration of amines |
12/03/1991 | CA1292693C Pharmaceutical preparation containing omeprazole |
12/03/1991 | CA1292686C Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
12/03/1991 | CA1292684C Diuretic composition containing furosemide |
12/02/1991 | WO1991018613A1 Self-emulsifying glasses |
12/02/1991 | CA2059555A1 Self-emulsifying glasses |
12/01/1991 | CA2043069A1 Cosmetic or pharmaceutical composition for the treatment of hair and scalp |
11/28/1991 | WO1991017772A1 Controlled release dopamine and its use to stimulate nerve fiber growth |
11/28/1991 | WO1991017751A1 Orally administrable gallium compositions and methods of treatment therewith |
11/28/1991 | WO1991017745A1 Filament system for delivering a medicament and method |
11/28/1991 | WO1991017744A1 Surgical implant and method incorporating chemotherapeutic agents |
11/28/1991 | WO1991017743A1 Slow release pharmaceutical compositions to be orally administered, and method for preparing same |
11/28/1991 | WO1991017718A1 Periodontal tissue regeneration barrier and method |
11/27/1991 | EP0458764A2 Device for taking and conveying tablets coming out of a rotary tabletting machine |
11/27/1991 | EP0458751A1 Delivery system for cyclic amino acids with improved taste, texture and compressibility |
11/27/1991 | EP0458745A1 Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
11/27/1991 | EP0458588A1 Treatment of ocular hypertension with a synergistic combination for ocular administration |
11/27/1991 | EP0457916A1 Plasma-irradiated solid preparation |
11/27/1991 | EP0457910A1 Novel glucosamine derivative and liposome containing the same as membrane component |
11/27/1991 | EP0457849A1 Electrotransport adhesive. |
11/27/1991 | EP0457837A1 Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |
11/27/1991 | EP0349593B1 Method of producing high aqueous volume multilamellar vesicles |
11/27/1991 | CN1056419A Process for making medical magnet |
11/27/1991 | CN1014861B Method of making dual coptis powder injection |
11/26/1991 | US5068249 Histamine H2 antagonist, (N-(2-(((5-(dimethylamino)methyl-2-furanyl)-methyl)thio)ethyl)-N'-methyl-2 -nitro-1,1-ethenediamine |
11/26/1991 | US5068226 Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies |
11/26/1991 | US5068225 Viscoelastic fluid for use in surgery and other therapies and method of using same |
11/26/1991 | US5068220 Biodegradable polyamides for providing a controlled release therapeutic drug |
11/26/1991 | US5068112 Controlled release pharmaceutical preparation and method for producing the same |
11/26/1991 | US5068111 Pharmaceutical tablets and capsule granulates of scleroglucan and active substance |
11/26/1991 | US5068110 Stabilization of enteric coated dosage form |
11/26/1991 | US5068109 Antacid composition |
11/26/1991 | US5068108 Controlled release protective matrices for zootechnical and veterinary use |
11/26/1991 | US5068103 Adhesive containing macromolecular substance and sequestering agent spread on support; prevention and treatment of asthma and bronchitis |
11/26/1991 | CA2043153A1 Delivery system for cyclic amino acids with improved taste, texture and compressibility |
11/25/1991 | WO1991017742A1 Sustained release suppository |
11/21/1991 | EP0457687A1 Screening cosmetic emulsion containing an UV-A screen and an UV-B screen |
11/21/1991 | EP0457578A1 Capsule-shaped tablet |
11/21/1991 | EP0457333A2 Topical composition |
11/21/1991 | EP0457326A1 Antiviral agents |
11/21/1991 | EP0457223A1 Stabilized fibroblast growth factor composition |
11/21/1991 | EP0457127A2 Spermicidal coating |
11/21/1991 | EP0457075A2 Process for the preparation of dust and binderfree, free flowing spray granulates or microgranulates of riboflavin from pure riboflavin |
11/21/1991 | EP0456928A1 Pasty dialyzing composition for perfusing artificial kidney systems and process for preparing same |
11/21/1991 | EP0456792A1 IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH |
11/21/1991 | EP0325628B1 Agent containing salicylic acid for treating lepidosis |
11/21/1991 | DE4021084C1 Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant |
11/19/1991 | US5066647 Freeze dried, quick dissolving, improved shelf life |
11/19/1991 | US5066495 Improving shelf life by mixing with excipient, reduced moisture content |
11/19/1991 | US5066494 Transdermal therapeutic system |
11/19/1991 | US5066441 Process for compacting a calcium phosphate composition |
11/19/1991 | US5066436 Microencapsulating Bioactive Substances In Biocompatible Polymers |
11/19/1991 | US5065866 Storage phosphor cassette assembly |
11/19/1991 | CA1292184C Treatment of systematic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics |
11/19/1991 | CA1292183C In-situ preparation and delivery of liposomes |
11/19/1991 | CA1292182C Intrapulmonary delivery of polypeptide growth factors and cytokines |
11/19/1991 | CA1292168C Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles |
11/18/1991 | WO1991017752A1 Percutaneous preparation containing estradiol |